13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C
- PMID: 18339592
- DOI: 10.1016/j.dld.2008.01.013
13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C
Abstract
Background: The (13)C-methacetin-breath test and also several noninvasive blood tests comprising routine laboratory parameters have been proposed to predict fibrosis and cirrhosis in chronic hepatitis C. The aim of the study was to compare the diagnostic accuracy between these tests referring to hepatic histology as gold standard.
Methods: 96 patients with chronic hepatitis C virus infection underwent percutaneous liver biopsy and the (13)C-methacetin-breath test. The Fibroindex, the aspartate aminotransferase to platelet ratio index , and the aspartate aminotransferase to alanine aminotransferase ratio were used as parameters for the staging of fibrosis. The main endpoint was the area under the characteristic curves for the diagnosis of advanced fibrosis (F3-F4) and cirrhosis (F4) according to the Batts Ludwig criteria.
Results: ROC analysis revealed a cut-off <14.6 per thousand best with 92.6% sensitivity and 84.1% specificity for the (13)C-methacetin-breath test, for the Fibroindex >1.82 70.4% sensitivity and 91.3% specificity, for the aspartate aminotransferase to platelet ratio >1.0 a 66.7% sensitivity and 75.4% specificity, and for the aspartate aminotransferase to alanine aminotransferase ratio >1.0 63.0% sensitivity and 59.4% specificity in predicting liver cirrhosis. The areas under the curve for the breath test, the Fibroindex, aspartate aminotransferase to platelet ratio and the aspartate aminotransferase to alanine aminotransferase ratio were 0.958, 0.845, 0.799, and 0.688, respectively, when predicting cirrhosis. For identifying patients with advanced fibrosis, the areas under the curve were 0.827, 0.804, 0.779, and 0.561, respectively. Discordances between Fibroindex (21%), aspartate aminotransferase to platelet ratio (29%) or aspartate aminotransferase to alanine aminotransferase ratio (37.6%) and liver biopsy were significantly more frequent than between (13)C-breath test (11.6%) and liver biopsy (P<0.05).
Conclusion: The (13)C-methacetin-breath test is more reliable in predicting advanced fibrosis and cirrhosis than simple biochemical parameters (aspartate aminotransferase to platelet ratio; aspartate aminotransferase to alanine aminotransferase ratio).
Similar articles
-
13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection.Aliment Pharmacol Ther. 2005 Jan 15;21(2):179-85. doi: 10.1111/j.1365-2036.2005.02317.x. Aliment Pharmacol Ther. 2005. PMID: 15679768
-
Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.Hepatology. 2005 Jun;41(6):1376-82. doi: 10.1002/hep.20717. Hepatology. 2005. PMID: 15915455
-
Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.Liver Int. 2008 Apr;28(4):486-93. doi: 10.1111/j.1478-3231.2008.01675.x. Liver Int. 2008. PMID: 18339075
-
Noninvasive monitoring of patients with chronic hepatitis C.Hepatology. 2002 Nov;36(5 Suppl 1):S57-64. doi: 10.1053/jhep.2002.36800. Hepatology. 2002. PMID: 12407577 Review.
-
Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C.Eur J Gastroenterol Hepatol. 2009 Jan;21(1):28-38. doi: 10.1097/MEG.0b013e32830cebd7. Eur J Gastroenterol Hepatol. 2009. PMID: 19060630 Review.
Cited by
-
(13C)-Methacetin breath test provides evidence of subclinical liver dysfunction linked to fat storage but not lifestyle.JHEP Rep. 2020 Nov 4;3(1):100203. doi: 10.1016/j.jhepr.2020.100203. eCollection 2021 Feb. JHEP Rep. 2020. PMID: 33490935 Free PMC article.
-
Diagnostic value of the C methacetin breath test in various stages of chronic liver disease.Gastroenterol Res Pract. 2011;2011:235796. doi: 10.1155/2011/235796. Epub 2011 Jun 7. Gastroenterol Res Pract. 2011. PMID: 21687605 Free PMC article.
-
European guideline on indications, performance and clinical impact of 13 C-breath tests in adult and pediatric patients: An EAGEN, ESNM, and ESPGHAN consensus, supported by EPC.United European Gastroenterol J. 2021 Jun;9(5):598-625. doi: 10.1002/ueg2.12099. Epub 2021 Jun 14. United European Gastroenterol J. 2021. PMID: 34128346 Free PMC article. Review.
-
(13)CO2 breath tests in non-invasive hepatological diagnosis.Prz Gastroenterol. 2015;10(1):1-6. doi: 10.5114/pg.2014.47501. Epub 2015 Jan 14. Prz Gastroenterol. 2015. PMID: 25960807 Free PMC article. Review.
-
13C Methacetin Breath Test for Assessment of Microsomal Liver Function: Methodology and Clinical Application.Gastroenterol Res Pract. 2017;2017:7397840. doi: 10.1155/2017/7397840. Epub 2017 Jul 5. Gastroenterol Res Pract. 2017. PMID: 28757868 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous